TOVX · AMEX
Theriva Biologics (TOVX) Stock Price & Fundamentals
Theriva Biologics (TOVX) closed at $919.38 on Oct 9, 2026, up 1.20% from the previous close of $908.44.
Share price, past year
1Y +53.04%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $919.38 |
| Sep 30, 2026 | $892.58 |
| Aug 31, 2026 | $875.71 |
| Jul 31, 2026 | $828.35 |
| Jun 30, 2026 | $799.02 |
| May 29, 2026 | $751.20 |
| Apr 30, 2026 | $725.52 |
| Mar 31, 2026 | $698.75 |
| Feb 27, 2026 | $659.27 |
| Jan 30, 2026 | $660.47 |
| Dec 31, 2025 | $636.07 |
| Nov 28, 2025 | $684.80 |
| Oct 31, 2025 | $659.13 |
Key statistics
- Market cap
- $42.19B
- P/E (TTM)
- 718.3
- EPS (TTM)
- $1.28
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 45.9M
- Dividend yield
- —
- 52-week range
- $600.73 – $930.19
Theriva Biologics's market cap is $42.19B, based on a share price of $919.38 and 45.9M shares outstanding as of Jun 30, 2026.
Financials
Theriva Biologics reported revenue of $0.00 for fiscal 2011, down 100.00% from fiscal 2010.
Theriva Biologics reported a net loss of $18.35M in fiscal 2023.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2011ended Dec 31, 2011 | $0.00 | −100.0% | — | — | — | — |
| FY2010ended Dec 31, 2010 | $2.61M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $300.00K | — | −$0.05 |
| Q3 FY2011ended Sep 30, 2011 | $293.42K | — | — |
| Q2 FY2011ended Jun 30, 2011 | $355.56K | — | — |
| Q3 FY2010ended Sep 30, 2010 | $289.90K | — | — |
| Q2 FY2010ended Jun 30, 2010 | $2.19M | — | — |
Company profile
- Name
- Theriva Biologics, Inc.
- Ticker
- TOVX
- Exchange
- AMEX
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 9605 Medical Center Drive, Suite 270, Rockville, MD 20850
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0000894158
Recent SEC filings
- Aug 11, 2026
- Aug 11, 2026
- Aug 6, 2026
- Aug 4, 2026
- Jul 7, 2026
- Jun 11, 2026
- Jun 5, 2026
- May 5, 2026
Frequently asked questions
What is Theriva Biologics's stock price?
Theriva Biologics (TOVX) closed at $919.38 on Oct 9, 2026, up 1.20% from the previous close of $908.44.
What is Theriva Biologics's market cap?
Theriva Biologics's market cap is $42.19B, based on a share price of $919.38 and 45.9M shares outstanding as of Jun 30, 2026.
How much revenue does Theriva Biologics make?
Theriva Biologics reported revenue of $0.00 for fiscal 2011, down 100.00% from fiscal 2010.
What is TOVX's P/E ratio?
Theriva Biologics's price-to-earnings ratio is 718.3, based on trailing twelve-month diluted EPS of $1.28.
Sources and methodology
Fundamentals come from Theriva Biologics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures